ASR Nederland H1 profit jumps nearly 10%

Dutch insurer ASR Nederland reported a significant increase in its first-half profit, reaching 901 million euros for the period ending June 30, marking a 9.8% rise from the previous year's 821 million euros. The company's net profit also surged to 809 million euros, more than five times the 126 million euros recorded a year earlier.

This substantial growth was driven by improvements across all business lines and a notable surge in investment income. The Life segment, which is ASR's largest, played a crucial role in this increase, with its operating profit rising by 11.6% to 689 million euros. This was made possible by a higher investment margin and a decrease in the impact of the ultimate forward rate.

The Non-life segment saw a 4.6% rise in its operating result to 268 million euros, while fee-based businesses experienced an impressive 32.1% increase, largely due to the acquisition of HumanTotalCare. The combined ratio for the Non-life book, which is a key profitability indicator excluding health insurance, stood at 91.6%, surpassing the group's target range of 92-94%.

ASR's operating return on equity also improved to 15.4% from 14.2%, exceeding the company's 12% target. The Solvency II ratio, a measure of the company's capital adequacy relative to regulatory requirements, increased to 222% from 218% at the end of December, largely due to organic capital generation outweighing the impact of dividend payments and a completed share buyback of 175 million euros.

ASR's organic capital creation rose by 7.3% to 773 million euros. Additionally, the company raised its interim dividend by 9.4% to 1.39 euros per share.